Cargando…

COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management

BACKGROUND: Diabetes and cancer are the leading causes of mortality all over the world. Infectious diseases are more common and/or life-threatening in patients with diabetes. Cancer patients with diabetes are individuals that are more susceptible to the current COVID-19 pandemic. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Asghar, Kashif, Abu Bakar, Muhammad, Ashfaq, Sara, Alvi, Asim Munir, Shafiq, Waqas, Azmat, Umal, Siddiqi, Ahmed Imran, Farooq, Asim, Raza, Rabail, Siddique, Kashif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434633/
https://www.ncbi.nlm.nih.gov/pubmed/36059615
http://dx.doi.org/10.3389/fonc.2022.922579
_version_ 1784780919396106240
author Asghar, Kashif
Abu Bakar, Muhammad
Ashfaq, Sara
Alvi, Asim Munir
Shafiq, Waqas
Azmat, Umal
Siddiqi, Ahmed Imran
Farooq, Asim
Raza, Rabail
Siddique, Kashif
author_facet Asghar, Kashif
Abu Bakar, Muhammad
Ashfaq, Sara
Alvi, Asim Munir
Shafiq, Waqas
Azmat, Umal
Siddiqi, Ahmed Imran
Farooq, Asim
Raza, Rabail
Siddique, Kashif
author_sort Asghar, Kashif
collection PubMed
description BACKGROUND: Diabetes and cancer are the leading causes of mortality all over the world. Infectious diseases are more common and/or life-threatening in patients with diabetes. Cancer patients with diabetes are individuals that are more susceptible to the current COVID-19 pandemic. We investigated the clinical features of survivor and non-survivor COVID-19-infected cancer patients with diabetes. PATIENTS AND METHODS: We did a retrospective study of 43 diabetic cancer patients with PCR-confirmed COVID-19 infection from Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan between March 03, 2020, and May 18, 2021. These patients either were discharged from the hospital or had died by Jun 16, 2021. Clinicopathological and radiological features were compared between survivors and non-survivors by fisher’s exact test and chi-square test. RESULTS: Forty-three diabetic cancer patients with SARS-CoV-2 infection were enrolled and the majority were males 26 (60.5%). The overall mean age was 61.67 ± 11.80. 39 (90.7%) had solid tumors and 3 (7.0%) had hematological malignancies. Fever (74.4%) and dyspnea (58.1%) were the most common symptoms. Complications were reported in 36 (83.7%) patients; during the course of the disease. Additionally, all the deceased patients (n=15) had acquired the complications. 11 (25.6%) patients were admitted to an intensive care unit (ICU). Furthermore, 29 (67.4%) out of 43 patients showed abnormal features in the radiological findings. We found significantly elevated levels of C-reactive protein (P=0.005), serum lactate (P=0.01), albumin (P=0.02), alkaline phosphate (P=0.03), and neutrophil count (P=0.04) in the non-survivors as compared to the survivors. CONCLUSION: Cancer patients with diabetes are a vulnerable population in the current pandemic. Identifying how diabetes in cancer patients affects the severity of SARS-CoV-2 infection is crucial for the clinical management of these patients. Rigorous scrutiny of clinicopathological features of COVID-19 infected cancer patients with diabetes especially values of C-reactive protein, lactate, albumin, alkaline phosphate, neutrophils, and regular monitoring of blood glucose levels may play a critical role in the outcome of the disease.
format Online
Article
Text
id pubmed-9434633
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94346332022-09-02 COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management Asghar, Kashif Abu Bakar, Muhammad Ashfaq, Sara Alvi, Asim Munir Shafiq, Waqas Azmat, Umal Siddiqi, Ahmed Imran Farooq, Asim Raza, Rabail Siddique, Kashif Front Oncol Oncology BACKGROUND: Diabetes and cancer are the leading causes of mortality all over the world. Infectious diseases are more common and/or life-threatening in patients with diabetes. Cancer patients with diabetes are individuals that are more susceptible to the current COVID-19 pandemic. We investigated the clinical features of survivor and non-survivor COVID-19-infected cancer patients with diabetes. PATIENTS AND METHODS: We did a retrospective study of 43 diabetic cancer patients with PCR-confirmed COVID-19 infection from Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan between March 03, 2020, and May 18, 2021. These patients either were discharged from the hospital or had died by Jun 16, 2021. Clinicopathological and radiological features were compared between survivors and non-survivors by fisher’s exact test and chi-square test. RESULTS: Forty-three diabetic cancer patients with SARS-CoV-2 infection were enrolled and the majority were males 26 (60.5%). The overall mean age was 61.67 ± 11.80. 39 (90.7%) had solid tumors and 3 (7.0%) had hematological malignancies. Fever (74.4%) and dyspnea (58.1%) were the most common symptoms. Complications were reported in 36 (83.7%) patients; during the course of the disease. Additionally, all the deceased patients (n=15) had acquired the complications. 11 (25.6%) patients were admitted to an intensive care unit (ICU). Furthermore, 29 (67.4%) out of 43 patients showed abnormal features in the radiological findings. We found significantly elevated levels of C-reactive protein (P=0.005), serum lactate (P=0.01), albumin (P=0.02), alkaline phosphate (P=0.03), and neutrophil count (P=0.04) in the non-survivors as compared to the survivors. CONCLUSION: Cancer patients with diabetes are a vulnerable population in the current pandemic. Identifying how diabetes in cancer patients affects the severity of SARS-CoV-2 infection is crucial for the clinical management of these patients. Rigorous scrutiny of clinicopathological features of COVID-19 infected cancer patients with diabetes especially values of C-reactive protein, lactate, albumin, alkaline phosphate, neutrophils, and regular monitoring of blood glucose levels may play a critical role in the outcome of the disease. Frontiers Media S.A. 2022-08-18 /pmc/articles/PMC9434633/ /pubmed/36059615 http://dx.doi.org/10.3389/fonc.2022.922579 Text en Copyright © 2022 Asghar, Abu Bakar, Ashfaq, Alvi, Shafiq, Azmat, Siddiqi, Farooq, Raza and Siddique https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Asghar, Kashif
Abu Bakar, Muhammad
Ashfaq, Sara
Alvi, Asim Munir
Shafiq, Waqas
Azmat, Umal
Siddiqi, Ahmed Imran
Farooq, Asim
Raza, Rabail
Siddique, Kashif
COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title_full COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title_fullStr COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title_full_unstemmed COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title_short COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management
title_sort covid-19 in cancer patients with diabetes in pakistan: clinical features and management
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434633/
https://www.ncbi.nlm.nih.gov/pubmed/36059615
http://dx.doi.org/10.3389/fonc.2022.922579
work_keys_str_mv AT asgharkashif covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT abubakarmuhammad covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT ashfaqsara covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT alviasimmunir covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT shafiqwaqas covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT azmatumal covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT siddiqiahmedimran covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT farooqasim covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT razarabail covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement
AT siddiquekashif covid19incancerpatientswithdiabetesinpakistanclinicalfeaturesandmanagement